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Connectivity in Glaucoma: A
Systematic Review
Raffaele Nuzzi*, Laura Dallorto and Teresa Rolle
Eye Clinic, Department of Surgical Sciences, University of Torino, Turin, Italy
Background: Glaucoma is a leading cause of irreversible blindness worldwide. The
increasing interest in the involvement of the cortical visual pathway in glaucomatous
patients is due to the implications in recent therapies, such as neuroprotection and
neuroregeneration.
Objective: In this review, we outline the current understanding of brain structural,
functional, andmetabolic changes detectedwith themodern techniques of neuroimaging
in glaucomatous subjects.
Methods: We screened MEDLINE, EMBASE, CINAHL, CENTRAL, LILACS, Trip
Database, and NICE for original contributions published until 31 October 2017. Studies
with at least six patients affected by any type of glaucoma were considered. We included
studies using the following neuroimaging techniques: functional Magnetic Resonance
Imaging (fMRI), resting-state fMRI (rs-fMRI), magnetic resonance spectroscopy (MRS),
voxel- based Morphometry (VBM), surface-based Morphometry (SBM), diffusion tensor
MRI (DTI).
Results: Over a total of 1,901 studies, 56 case series with a total of 2,381 patients were
included. Evidence of neurodegenerative process in glaucomatous patients was found
both within and beyond the visual system. Structural alterations in visual cortex (mainly
reduced cortex thickness and volume) have been demonstrated with SBM and VBM;
these changes were not limited to primary visual cortex but also involved association
visual areas. Other brain regions, associated with visual function, demonstrated a
certain grade of increased or decreased gray matter volume. Functional and metabolic
abnormalities resulted within primary visual cortex in all studies with fMRI and MRS.
Studies with rs-fMRI found disrupted connectivity between the primary and higher visual
cortex and between visual cortex and associative visual areas in the task-free state of
glaucomatous patients.
Conclusions: This review contributes to the better understanding of brain abnormalities
in glaucoma. It may stimulate further speculation about brain plasticity at a later age
and therapeutic strategies, such as the prevention of cortical degeneration in patients
with glaucoma. Structural, functional, and metabolic neuroimaging methods provided
evidence of changes throughout the visual pathway in glaucomatous patients. Other
brain areas, not directly involved in the processing of visual information, also showed
alterations.
Keywords: glaucoma, retinal ganglion cells, neurodegeneration, neuroplasticity, systematic review
Nuzzi et al. Brain and Glaucoma: A Systematic Review
INTRODUCTION
Rationale
Glaucoma is a leading cause of irreversible blindness worldwide
(Tham et al., 2014) and is characterized by the death of retinal
ganglion cells (RGC) and their axons (Weinreb et al., 2014). The
global incidence of primary open angle glaucoma (POAG) is
anticipated to increase to 65 million by 2020 (Kapetanakis et al.,
2016).
Numerous studies showed brain changes, especially in the
visual pathway in glaucoma (Gupta and Yücel, 2003; Davis et al.,
2016). The neurodegenerative process has been established in
glaucomatous damage (Gupta et al., 2007; Chang and Goldberg,
2012). As a matter of fact, POAG presents important analogies
with other neurodegenerative diseases: it has been shown that
RGC share the same cell death mechanisms with Alzheimer’s
disease, AD (McKinnon, 2012). Protein misfolding is one of
the identified mechanisms capable of triggering the apoptotic
cascade in glaucomatous pathogenesis (Wostyn et al., 2009).
Indeed, the β-amyloid deposits, characteristic of Alzheimer’s
disease, have recently been implicated in the pathogenesis of
glaucoma (Wostyn et al., 2010). The incidence of glaucoma is
increased in patients with AD compared to controls with the
same age (Bayer et al., 2002; Tamura et al., 2006). Furthermore,
the progression of visual field defects is accelerated in patients
with open-angle glaucoma and AD compared to patients with
open-angle glaucoma without AD (Bayer and Ferrari, 2002).
Moreover, nowadays, new treatments targeted visual
pathway. Several neuroprotective strategies and drugs have
been studied and some of them are used in the clinical practice.
Neuroprotection consist in the prevention of neurons death
(Jutley et al., 2017; Sena and Lindsley, 2017). Molecules that have
passed through clinical test are memantine (NMDA glutamate
receptor antagonist) and brimonidine (alpha2-adrenergic
agonist). Neuroprotection is not effective for RGCs which have
already been injured, thus neuroenhancement is also proposed
as a therapeutic approach. Axon regeneration is the aim of
neurotrophic factors such as nerve growth factor (NGF) and
ciliary neurotrophic factor (CNTF). Human trials using these
exogenous neurotrophic factors showed promising results but
of limited duration and with the inconvenient of repeated
injections. In recent years, stem cells have been widely studied as
potential source of cell replacement. Several types and methods
of administration (subtenionan, retrobulbar, and intravitreal)
have been proposed and experimented in clinical trials even in
humans. Another approach, still limited to murine examples, is
the RGC transplantation. Preliminary data showed promising
approach in retinas with degenerating RGCs (Venugopalan et al.,
2016). Finally, retinal implants provide electrical stimulation of
different targets but their clinical application is limited due to
limited visual perception (Mathieson et al., 2012).
The efficacy of these modern approaches impose a deep
knowledge of, cortical reorganization, neuroplasticity, and
rearrangement of the visual pathways in glaucoma. Almost all
approaches targeted RGCs of optic nerve require the integrity
of posterior visual pathway or the adaptation of nervous
system through plastic capacity. Moreover, new insights into
brain changes in glaucoma may stimulate new therapeutic
strategies.
The advent of non-invasive brain-imaging techniques has
led to a rapid growth in studies investigating the brain
damage in glaucomatous patients. Newer techniques and
protocols enable the study of anatomical gray and white
matter changes through structural techniques, brain connectivity
and functional responses after stimulation through functional
magnetic resonance imaging (fMRI) and changes in brain
metabolite levels through metabolic technique (Fiedorowicz
et al., 2011; Mastropasqua et al., 2015; Brown et al., 2016; Prins
et al., 2016).
Structural brain techniques include diffusion MRI (diffusion
tensor imaging, DTI) which can reveal abnormalities in white
matter structure and brain connectivity through diffusivity of
water molecules along the axons (Alexander et al., 2007).
Voxel-based morphometry analysis (VBM) which is computed
on MRI, quantifies the tissue concentration of gray and
white matter volume (Ashburner and Friston, 2000). Surface-
based morphometry (SBM), throughT1-weighted morphometric
analysis, provides data about the brain structure, such as
thickness, curvature, and surface area of brain cortex (Clarkson
et al., 2011).
Functional magnetic resonance imaging (fMRI) is a
neuroimaging procedure capable to detect functional brain
activities after a stimulus through detecting changes in blood
flow (Miki et al., 2001, 2002; Kollias, 2004). It is also used to
evaluate interactions between brain areas in a resting subject
without any visual stimulus, the so-called “resting state fMRI”
(Smitha et al., 2017). Finally, metabolic method such as the
proton magnetic resonance spectroscopy (MRS) is able to detect
and quantify certain biochemical compounds in brain tissue
(Boucard et al., 2007).
Objective
This systematic review focuses on brain changes detected with the
modern techniques of neuroimaging (structural, functional, and
metabolic methods) in glaucomatous subjects.
Research Question
What have studies on neuroimaging in glaucomatous patients
found thus far?
When do brain changes occur and what is the cause of these
changes in the glaucomatous patients?
METHODS
We adopted the Preferred Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines.
Search Strategy
We searched: MEDLINE (Ovid), CENTRAL (which contains
the Cochrane Eyes and Vision Group Trials Register), EMBASE
(Ovid), Latin American and Caribbean Literature on Health
Sciences (LILACS), CINAHL (EBSCO), Trip Database, and
The National Institute for Health and Care Excellence (NICE).
The construction of search strategies was performed using
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database specific subject headings and keywords. The MEDLINE
search strategy was provided as Supplementary Material
(Supplementary Data 1). These searches were supplemented by
hand searching the bibliographies of all the included studies.
Gray literature was not considered. Accepted languages of
publication were: English, German, French, Spanish, Portuguese
and Italian. Articles published until October 31, 2017 were
included.
Study Design
Randomized controlled trials (RCT), clinical trials, non-
randomized comparative studies, cohort studies, and case series
(CS) were included.
Case report, case series with <6 patients and article with
absence of outcome data were excluded.
Participants, Interventions, Comparators
We included studies on patients affected by POAG, primary angle
closure glaucoma (PACG), and normal tension glaucoma (NTG).
Glaucomatous damage could be both unilateral and bilateral.
Stages of glaucoma were not exclusion criteria.
We included studies using the following neuroimaging
techniques:
- Diffusion tensor MRI (DT MRI/ DTI)
- Voxel- based Morphometry (VBM)
- Surface-based Morphometry (SBM)
- Functional Magnetic Resonance Imaging (fMRI)
- Resting-state fMRI (rs-fMRI)
- Magnetic resonance spectroscopy (MRS)
Data Sources, Studies Sections, and Data
Extraction
According to the PRISMA flow diagram screening of titles and
abstracts was carried out. Not pertinent articles were rejected.
Duplicates were removed using EPPI reviewer (by EPPI-Center,
Social Science Research Unit, the Institute of Education, the
University of London, UK). After this initial selection, full texts
were independently judged for eligibility.
Data Analysis
The main outcome of this systematic review was the current
understanding of brain changes in glaucomatous subjects.
Structural, functional, and metabolic neuroimaging results
were separately analyzed and presented, but their interaction
was nonetheless studied. Differences between various types of
glaucoma and various stages of disease were analyzed.
Specifically, characterizing parameters of each neuroimaging
method are listed below:
- DTI: fractional anisotropy (FA), mean diffusivity (MD), and
radial diffusivity (RD). They all are measures of white matter
damage.
- VBM: gray matter and white matter volume.
- SBM: thickness, curvature, and surface area of brain cortex.
- fMRI: Blood oxygenation level dependent (BOLD) evaluation.
It detects changes in the blood flow of local brain regions
through changes in hemoglobin and unoxygenated
hemoglobin in the blood. In the manuscript we referred
to fMRI for “task-fMRI,” which measures responses during
visual tasking
- rs-fMRI: Voxel-wise degree centrality (DC), that is the direct
connections for a given voxel in the voxel-wise connectome,
and functional connectivity (FC) between areas in resting
conditions, without any visual tasks
- MRS: concentrations of the metabolites such as N-




A total of 1,901 studies were screened using the described search
strategy. At the end of the selection process, 56 case series
were included in the systematic review. Prisma flow diagram
(Figure 1) gives details on screening process.
Thirty-one out of 56 (55%) studies examined brain changes
in terms of structural parameters (19 studies used DTI, 6 studies
VBM, 4 studies SBM, one single study both VBM and SBM, and
one single study both VBM and DTI). Nineteen out of fifty-
six studies, (34%) used functional techniques to evaluate brain
changes following glaucomatous degeneration (10 studies used
the fMRI and 9 studies the rs-fMRI). Metabolic methods (MRS)
are used in 2 studies (4%). Four studies (7%) used both structural
and functional techniques on the same group of patients: three
studies used rs-fMRI, VBM, and DTI, one study used VBM
and fMRI.
Study Characteristics
A total of 1,326 patient and 1,055 controls were considered in
this systematic review. Forty-nine studies included POAGpatient
(41 studies only POAG patients, 7 studies included both POAG
and NTG, one single study had both POAG and PACG). A total
of 1,061 patient, corresponding to 80% of the total number had
POAG. 154 out of 1326 (12%) patients were affected by PACG
(they are included in seven studies, one of these studies included
both POAG and PACG patients). NTG was the less studied type,
corresponding to 8% (111 patients) of the total. Eight studies
included NTG patients, 7 studies had both NTG and POAG
patients, one single study had NTG patients).
Patients characteristics of included studies are reported in
Table 1. Patients included in this review show high heterogeneity
in mean age ranging from 25 (Dai et al., 2013) to 76 (Bogorodzki
et al., 2014) years. Severity of glaucoma damage varies from
early to severe and some authors included different stages in the
same study. Method of severity classification was not consistent
throughout all studies, even though themost used is theHodapp–
Parrish–Anderson (HPA) classification.
Outcomes of Structural Analysis
Results of studies analyzing structural brain changes in
glaucomatous patients are reported in Table 2.
Diffusion tensor imaging methodology has been extensively
used to investigate differences in white matter tracts of visual
pathway within glaucoma (19 out of 56 studies, 34% of all
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FIGURE 1 | Prisma flow diagram.
included studies). Decreased fractional anisotropy (FA) and
increased mean diffusivity (MD) and radial diffusivity (RD) are
sign of axon injury. Differences of microstructure in white matter
structures have been found in the optic nerve, optic tracts, optic
chiasm, optic radiations, and occipital lobe. These results were
obtained in studies including POAG (Garaci et al., 2009; El-
Rafei et al., 2011, 2013; Engelhorn et al., 2011; Bolacchi et al.,
2012; Nucci et al., 2012; Zhang et al., 2012; Zikou et al., 2012;
Chen Z. et al., 2013; Lu et al., 2013; Michelson et al., 2013;
Frezzotti et al., 2014, 2016; Kaushik et al., 2014; Omodaka et al.,
2014; Schoemann et al., 2014; Sidek et al., 2014; Murai et al.,
2015; Tellouck et al., 2016; Zhou et al., 2017a; Giorgio et al.,
2018), NTG (Boucard et al., 2016) and PACG (Wang et al., 2013)
patients.
Some of the studies using DTI methodology found alterations
of white matter integrity not limited to the primary visual
pathway. Boucard et al. (2016) revealed damage of corpus
callosum and parietal lobe in NTG, Frezzotti et al. (2016) found
alterations in the longitudinal fascicle, supramarginal gyrus, and
superior parietal lobule of early stage open angle glaucoma.
In addition, according to Giorgio et al study (Giorgio et al.,
2018), superior longitudinal fascicle, white matter adjacent to
precuneus, inferior frontal gyrus, and superior parietal lobe
had microstructural alterations in both normal tension and
open angle glaucoma compared to healthy subjects (Giorgio
et al., 2018). Such white matter structures are related to higher
aspects of visual and cognitive process. Furthermore, significant
decreased FA was found in glaucomatous compared to healthy
subjects in the inferior fronto-occipital fasciculus (implied in
visuospatial function), longitudinal and inferior frontal fasciculi
(related to visual memory), putamen, caudate nucleus, anterior,
and posterior thalamic radiations and anterior and posterior
limbs of the internal capsule (implied in direction, color, and
orientation; Zikou et al., 2012).
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Dependence on glaucoma severity of changes in white matter
tissue studied with DTI was demonstrated. Glaucoma severity
showed a negative correlation with FA, and a positive correlation
with MD and RD values of white matter tracts involved in the
visual process (Garaci et al., 2009; Nucci et al., 2012; Zhang et al.,
2012; Chen Z. et al., 2013; Michelson et al., 2013; Wang et al.,
2013; Omodaka et al., 2014; Sidek et al., 2014; Tellouck et al.,
2016; Zhou et al., 2017a). Correlation was found between DTI
parameters and RNFL, mean deviation of visual field, cup-to-disc
ratio.
Significant gray matter reduction within the primary visual
cortex emerged from many studies using VBM (Hernowo et al.,
2011; Li et al., 2012; Zikou et al., 2012; Chen W. W. et al., 2013;
Williams et al., 2013; Frezzotti et al., 2014, 2016; Zhang et al.,
2015; Wang et al., 2016; Jiang et al., 2017; Giorgio et al., 2018).
Specifically, a significant reduction was found only in the anterior
part of occipital pole (Boucard et al., 2007) strengthen the idea of
retinotopic damage. Other studies showed clusters of gray matter
reduction in glaucoma patients in areas other than occipital pole,
including the lingual gyrus, calcarine gyrus, postcentral gyrus,
superior frontal gyrus, inferior frontal gyrus, rolandic operculum,
cerebellar cortex, and hippocampi (Li et al., 2012; Chen W. W.
et al., 2013; Frezzotti et al., 2014).
The extent of gray matter atrophy was dependent on the level
of glaucoma severity (Li et al., 2012; Zhang et al., 2015; Wang
et al., 2016). Indeed, Frezzotti et al found lower gray matter
volume only in advanced POAG (Frezzotti et al., 2016).
Moreover, gray matter was increased in some brain areas
(middle temporal gyrus, inferior parietal gyrus, angular gyrus,
midbrain, brainstem, frontal gyrus, cerebellar vermis, thalamus)
of glaucomatous patients (Li et al., 2012; ChenW.W. et al., 2013;
Williams et al., 2013; Jiang et al., 2017). All these brain regions
involved were associated with visual functions.
Alterations in visual cortex has been demonstrated also with
SBM. In particular, the five studies using SBM demonstrated
a thinning in the visual cortex of POAG (Bolacchi et al.,
2012; Yu et al., 2013, 2014, 2015; Wang et al., 2016). Reduced
cortex thickness was not limited to primary visual cortex, but
also involved association visual areas, such as lingula, fusiform
gyrus, cuneus, middle temporal gyrus (Bolacchi et al., 2012; Yu
et al., 2013, 2014, 2015). Positive correlation was found between
thinning of visual cortex and clinical measurements (Yu et al.,
2013, 2014, 2015; Wang et al., 2016). Correlation with glaucoma
severity was also demonstrated by significant differences of visual
cortex thickness between mild and severe glaucoma groups, with
increased damage in late-stage glaucoma (Yu et al., 2013).
Outcomes of Functional and Metabolic
Analysis
Studies reporting functional and metabolic activity in
glaucomatous patients are reported in Table 3.
Functional activity resulted greatly reduced within primary
visual cortex after visual input from the glaucomatous eye in all
studies using fMRI both in POAG (Duncan et al., 2007a; Qing
et al., 2010; El-Rafei et al., 2013; Lestak et al., 2014; Borges et al.,
2015; Gerente et al., 2015; Murphy et al., 2016; Zhang et al., 2016;
Jiang et al., 2017; Zhou et al., 2017b), NTG (El-Rafei et al., 2013;
Lestak et al., 2014; Zhang et al., 2016) and PACG patients (Song
et al., 2012).
Resting state fMRI (Rs-fMRI) is a tool for studying the human
brain functional connectivity in resting state, without visual
stimulation (Biswal et al., 2010). Voxel-wise degree centrality
(DC) represents the number of connections for a given voxel and
it, thus, quantifies the ability for information integration. The
decreased connectivity was found in areas related to vision and
also in other networks related to working memory and attention
in POAG patients (Dai et al., 2013; Frezzotti et al., 2014, 2016;
Chen et al., 2017; Giorgio et al., 2018). Decreased functional
connectivity even without visual tasking was also observed in the
bilateral visual cortices of PACG patients (Boucard et al., 2016).
Metabolic neuronal dysfunction was studied through
quantification of certain biochemical compounds with proton
MRS in two studies. The main brain metabolites studied by MRS
included N-acetylaspartate (NAA), Choline (Cho), and Creatine
(Cr). NAA is localized within neurons and a decreased in NAA
concentration is a sign of neuronal loss. Choline is a marker
of membrane integrity, it decreases when a damage of neurons
occurred. Creatinine, implied in energy metabolism, should
remain constant throughout the brain even in neurodegenerative
disease. Its concentration is used to calculate metabolic ratio
such as NAA:Cr and Cho:Cr. Results of the two studies using
MRS were contradictory, Boucard et al (Boucard et al., 2007)
found no significant differences in the brain metabolites between
the patients and the control group. On the contrary, Zhang et al.
(2013), found decreased brain metabolites which are marker
for neuronal integrity in geniculo-calcarine and striate area of
occipital pole.
DISCUSSION
Studies of glaucomatous degeneration in the brain were initially
based on experiments conducted on monkey who were induced
glaucoma. The studies identified degeneration at the lateral
geniculate nucleus (LGN) and primary visual cortex (V1) in
response to increased IOP and optic nerve damage (Yücel
et al., 2000, 2001). These results were supported by the
same results in post-mortem human studies that reported
a significant neurodegeneration in optic nerve, LGN and
visual cortex in a glaucoma patient (Gupta et al., 2006). The
advent of non-invasive brain imaging techniques has led to an
increase in studies investigating the involvement of the brain in
glaucoma pathology. The detection of brain neurodegeneration
in glaucomatous subjects could open new future frontiers. As an
example, innovative brain imaging methods have been proposed
in the early detection of the disease and in the evaluation of
therapeutic efficacy of novel neuroprotective strategies (Brown
et al., 2016). This systematic review is aimed at bringing together
different results deriving from other research regarding brain
involvement in patients with glaucoma.
Integration of Structural and Functional
Results
Studying brain changes in glaucoma patients both structurally,
functionally, and metabolically provides for more information.
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White Matter of Visual Pathway (NO, NT, OR)
Many studies using DTI demonstrated glaucomatous
degeneration of the optic nerve (Garaci et al., 2009; Bolacchi
et al., 2012; Nucci et al., 2012; Zhang et al., 2012; Wang et al.,
2013; Omodaka et al., 2014), optic tract (Chen Z. et al., 2013;
Frezzotti et al., 2014, 2016; Kaushik et al., 2014; Zhou et al.,
2017a; Giorgio et al., 2018), and optic radiation (Garaci et al.,
2009; El-Rafei et al., 2011, 2013; Engelhorn et al., 2011; Hernowo
et al., 2011; Bolacchi et al., 2012; Chen Z. et al., 2013; Lu et al.,
2013; Michelson et al., 2013; Frezzotti et al., 2014, 2016; Kaushik
et al., 2014; Schoemann et al., 2014; Sidek et al., 2014; Gerente
et al., 2015; Huang et al., 2015; Murai et al., 2015; Tellouck et al.,
2016; Jiang et al., 2017; Zhou et al., 2017a; Giorgio et al., 2018).
These findings are corroborated by other techniques, such as
VBM. Subjects with glaucoma exhibited significant reductions
in the volume of the visual pathway, including the optic nerves,
chiasm, tracts, LGN, and optic radiations (Hernowo et al., 2011).
El-Rafei et al. demonstrated the ability of DTI- derived
measures to differentiate between glaucomatous patients and
healthy subjects but also between different glaucoma types
(POAG and NTG) with an accuracy of 98.3% (El-Rafei et al.,
2013).
According to Engelhorn’s study (Engelhorn et al., 2011),
rarefaction of optic radiation correlated both with the extent
of optic nerve atrophy and with the extent of visual field
defect. Thus, degeneration of optic radiation seems to be the
result of anterograde transneuronal degeneration. Interestingly,
the same study demonstrated a high prevalence (80%) of
microangiopathic lesions within the optic radiation supporting
the concept of retrograde degeneration of RGCs starting from the
optic radiation. Moreover, axonal impairment of optic radiation
studied with DTI demonstrated good correlation with cerebral
glucose hypometabolism in the striate cortex of POAG patients
(Murai et al., 2015).
Primary Visual Area
In regard to primary visual cortex (V1), loss of gray matter at
SBM (Bolacchi et al., 2012; Yu et al., 2013, 2014, 2015;Wang et al.,
2016) and VBM (Boucard et al., 2009; Li et al., 2012; Zikou et al.,
2012; Chen W. W. et al., 2013; Frezzotti et al., 2014; Zhang et al.,
2015; Giorgio et al., 2018) analysis is consistent with a reduction
of function proved by fMRI studies (Duncan et al., 2007a; Qing
et al., 2010; Song et al., 2012; El-Rafei et al., 2013; Borges et al.,
2015; Gerente et al., 2015; Murphy et al., 2016; Zhang et al., 2016;
Jiang et al., 2017; Zhou et al., 2017b).
Using VBM, Boucard et al. (2007) showed a retinotopic
specific gray matter reduction in primary visual cortex. Indeed,
POAG subjects showed a reduction in gray matter density mainly
in the anterior part of occipital pole, while AMD patients showed
a reduction located more posteriorly in occipital cortex, in
correspondence with the location of the foveal representation in
visual cortex.
Nevertheless, the study of Boucard et al. (2007) investigating
the concentrations of metabolites such as N-acetylaspartate
(NAA) in occipital pole using MRS, showed no alterations in
patients with POAG compared to healthy subject. This could
be explained with either absence of occipital degeneration or
degeneration occurring with a slow rate, undetectable with MRS.
The MRS method presents a limitation: it only measures reduced
NAA levels when the degenerative process is currently taking
place.
Interestingly, the deterioration of cortical activity and
structure in V1 correlated with structural measurement of
optic disc. Structural analysis of optic disc damage was
conducted with scanning laser polarimetry with variable
corneal compensation (GDx-VCC), confocal scanning laser
ophthalmoscopy (SLO), and optical coherence tomography
(OCT). In addition, functional activity of V1 is altered in a
manner consistent with the loss of visual function (Duncan et al.,
2007b), indicating that visual deprivation can have a potential
effect on brain structure and function.
Higher Visual Areas and Connection Between Visual
Areas
Many of the above-mentioned studies demonstrated the effect
of glaucoma on higher visual areas, which are the secondary
or associative areas of vision. Some of these studies showed a
decreased functional activation after visual stimulation of the
higher visual areas (Borges et al., 2015) and also a decreased
cortical volume of associative areas (Bolacchi et al., 2012; Yu
et al., 2013, 2014, 2015). The more plausible explanation of these
changes is the transynaptic neurodegeneration. Other studies
however found an increased functional activity in some higher
visual areas (Jiang et al., 2017) and even an increased volume in
some visual associative areas (Li et al., 2012; Chen W. W. et al.,
2013;Williams et al., 2013; Jiang et al., 2017). Increased functional
activity could be a result of reduced feedback signals from visual
areas causing a reduction in GABA-mediated inhibitor signal
(Chen et al., 2017). According to this latter hypothesis, visual
area has an inhibition effect on some visual associative areas.
Since the primary visual area is damaged in glaucoma, there is
a reduction of inhibition that should cause a greater functional
response to fellow eye input within the lesion projection zone.
This was proved in murine (Crozier et al., 2007) and primate
(Biswal et al., 2010) models but not in human eye (Boucard
et al., 2007).Results of increased gray matter volume in visual
association areas are more difficult to interpret. The increased
volume t of these areas could be a sign of neuronal damage
(microglia activation, neuronal swelling) or of increased cortical
functionality and plasticity (increased arborization of dendrites
and axons). The Jiang’s study (Jiang et al., 2017) analyzed the
same areas both in terms of volume with VBM and in terms
of functional activity through BOLD level with the fMRI. Jiang
et al. found that volume changes were not fully consistent with
the regional blood flow changes; only frontal and parietal lobes
have overlapped results. Increased volume in other areas without
functional activation could be explained as the result of cell
edema, sign of nerve damage.
Dai et al. (2013) found disrupted connectivity between the
primary and higher visual cortex and between visual cortex
and associative visual areas in the task-free state. Diminished
connectivity between these areas may be associated with
impairment in memory-related imagery, visual consolidation
and integration of visual, auditory and tactile stimulation. In
Frontiers in Neuroscience | www.frontiersin.org 16 May 2018 | Volume 12 | Article 363
Nuzzi et al. Brain and Glaucoma: A Systematic Review
addition to areas of decreased connectivity, some brain regions of
POAG patients showed increased connectivity with visual cortex.
These changes could be related to recruitment to compensate
areas of decreased activity or, alternatively, may be related to loss
of inhibitor input.
Decreased connectivity in visual and working memory is
confirmed by Frezzotti et al. study (Frezzotti et al., 2014) and
it explains the impairment of object identification in POAG
patients.
PACG patients share the same decreased visual information
integration between the primary visual cortex and higher areas
(Huang et al., 2015; Li et al., 2017).
Areas Indirectly Involved in the Visual Pathway
Several of the studies that this paper is based on reported
alterations in areas not directly involved in the visual pathway.
A study which measured the brain connectivity with the
rs-fMRI in PACG patients (Cai et al., 2015) showed the
increased connectivity in the anterior cingulate cortex (ACC)
and the caudate, a component of the basal ganglia. The
ACC is responsible for cognition and emotional control; its
dysregulation in PACG patients could be caused by the higher
prevalence of anxiety and depression in glaucomatous patients
(Agorastos et al., 2013), even higher in PACG (Kong et al.,
2015). The increased connectivity in the caudate is explained
as a response to altered proprioception and somatosensory
processing.
Decreased spontaneous activity in the claustrum and
paracentral lobule lobe was observed in PACG patients using
the same technique (rs-fMRI) (Chen et al., 2017). These finding
may indicate impairment of the visuospatial function; the results
of Zikou et al corroborate this hypothesis for the same reason
(Zikou et al., 2012).
Alterations in extra-visual pathway areas are also
demonstrated with structural examinations. A recent study
using DTI (Boucard et al., 2016) demonstrated the degeneration
of the corpus callosum in a cohort of normal tension glaucoma.
This finding suggests the presence of neurodegeneration of the
brain beyond what can be explained on the basis of propagated
retinal and pre-geniculate damage. It is arduous to apply this
conclusions to POAG patients; it is more reasonable that NTG
has a different profile of neuronal cell death. Another area which
showed volumetric alteration in glaucomatous patients was the
amygdala that plays a role in the control of emotions (Wang
et al., 2016).
In Frezzotti’s study POAG patients showed gray matter
atrophy in regions involved in cognitive processing (Frezzotti
et al., 2014). In addition, several areas showed alteration in both
Alzheimer disease and glaucoma: the hippocampus, involved
in the memory process, the frontoorbital cortex (implied
in the decision-making) and superior parietal lobule (special
orientation).
While glaucoma normally manifest as a damage in main
cerebral visual areas, there are also alterations possibly related
to glaucoma in areas of the brain that are less known of. These
parts of the brain for example are involved in other functions,
emotional, decision making and memory.
Possible Causes of Cortical Changes in
Glaucoma Patients
Mechanisms involved in cortical changes of glaucomatous
patients remain debated. Also, the timing of the
neurodegenerative cortical process is still to be unanimously
ascertained. The main question is whether the cortical changes
precede or follow the RGC neurodegeneration. Many studies
supported the thesis that glaucomatous degeneration of the
posterior visual pathway is a consequence of anterograde
trans-synaptic diffusion of death signals triggered by RGC
degeneration (Calkins and Horner, 2012). Bolacchi et al. (2012)
analyzed the properties of the intraorbital optic nerve at two
different levels: proximal and distal to the optic nerve head
using the DTI. The study results indicate at early disease
stage a significant decrease in connectivity in the proximal
segment with respect to the distal site. Furthermore, reduced
brain volume in visual-related cortex was found only in
advanced stage glaucoma but not in early stage patients (Li
et al., 2012). Functional analysis through fMRI provided
a detailed analysis of layer-specific neuronal signals in the
subcortical visual nuclei (lateral geniculate nucleus and
superior colliculus) and visual cortex. It emerges that early-
stage glaucoma causes selective functional loss to large cells
(responsive to M stimulus) in the lateral geniculate nucleus
and superior colliculus, but not in the visual area (Zhang et al.,
2016).
On the other hand, similarities between glaucoma and other
neuro-degenerative diseases (including Alzheimer’s disease)
suggest a certain grade of retrograde trans-synaptic degeneration
as well. A demonstration of this theory is the presence of damage
also in areas not directly involved in the visual pathway (Cai
et al., 2015; Boucard et al., 2016). In addition, functional changes
in brain connectivity (Frezzotti et al., 2016; Murphy et al.,
2016) together with reduced brain volume were found in early
stage glaucoma, even before visual field damage (Murphy et al.,
2016).
Vascular changes also have a possible role in the
physiopathology as demonstrated by ischemic microinfarcts in
the optic radiation and other cortical regions (Boucard et al.,
2016).
Correlation of Structural and Functional
Parameters With Clinical Severity
Many studies investigated the correlation between structural,
functional and metabolic brain parameters and ophthalmic
measurement such as cup-disc ratio, retinal nerve fiber layer
thickness and visual field parameters (Hernowo et al., 2011; Nucci
et al., 2012; Chen Z. et al., 2013; Michelson et al., 2013; Sidek
et al., 2014; Cai et al., 2015; Gerente et al., 2015; Chen et al.,
2017; Li et al., 2017). Many studies found a positive correlation
with all these parameters, revealing that visual pathway damage
correlates with clinical severity in glaucoma (Nucci et al., 2012;
Chen Z. et al., 2013; Michelson et al., 2013; Sidek et al., 2014; Cai
et al., 2015; Gerente et al., 2015; Chen et al., 2017).
The relationship with loss of visual field has important
implications. In glaucoma a loss of ∼40−60% of the ganglion
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cells is already present when visual field defects are detectable
by perimetry (Quigley et al., 1989; Harwerth et al., 1999, 2005;
Kerrigan-Baumrind et al., 2000; Rolle et al., 2016). Structural
neuroimaging techniques, such as DTI, are able to detect axonal
injury of visual pathway at an early stage, even before visible
visual field defect.
Moreover, a decreased cortical activity in the primary visual
cortex is detected with fMRI in the cortical area corresponding
to the central normal field (Qing et al., 2010). As previously
reported, a big amount of RGC is lost before any abnormality
in automated visual field testing is detectable. The remaining
RGC undergo structural reorganization which consist in somata
and dendritic arbors expansions. Consequently, cortical visual
receptive filed increases in size. Thus, even if the central visual
field is normal, the retina input is already reduced and the activity
in visual cortex is reduced as well.
It is not surprising, that many authors propose neuroimaging
techniques as a tool for earlier diagnosis of glaucoma in the
future.
In regard to influence of glaucoma severity on brain changes,
it is somehow difficult to provide a systematic analysis mainly
because of differences in classification and parameters used to
divide patients. Nevertheless, while functional connectivity was
proved to be already altered in early POAG in both visual
and nonvisual systems (Frezzotti et al., 2016; Zhang et al.,
2016), structural changes (mainly gray matter atrophy) was
unanimously found in more advanced/severe POAG, but not
in all early POAG analyzed (Li et al., 2012; Zhang et al.,
2015). Studies investigating cortical geometry in mild and severe
POAG demonstrated a progressively aggravated degeneration
with the increasing severity of disease. Cortical degeneration
occurs not only in visual cortex (both V1 and V2), but
also in the middle temporal visual area (V5/MT+), which is
thought to be specialized for processing motion (Yu et al., 2014,
2015).
Overall, structural, functional, and metabolic brain changes
show a good correlation with clinical measurement of severity.
Neuronal Plasticity
Many human studies including those of this review have
suggested that even during adulthood the visual cortex maintains
the ability to structurally and functionally reorganize (Rosa
et al., 2013). Visual cortical plasticity was also proved in
healthy subjects after visual training (Berry and Nedivi, 2016).
Neuroplasticity can be both structural, which implies changes
in axons, and functional (Rosa et al., 2013). Functional
reorganization is related to the unmasking of intracortical
feedback to early visual cortex from higher visual areas (Crozier
et al., 2007; Biswal et al., 2010).
Postoperative enhancement in neuronal connectivity was
demonstrated in a group of PACG patients 3 months after
surgery with normalization of IOP (Cai et al., 2015). The areas
that showed a better connectivity were visual cortex, primary,
sensory, and supplementary motor areas Further studies (Li et al.,
2017) demonstrated functional restoration after glaucomatous
surgery and IOP normalization. One possible explanation for
this result is the post-operative plasticity in functional networks.
These changes can occur 3 months after the surgery, and it is
possible that they are due to restoration process. Li et al. found
a decreased connectivity of the visual area with the resting state-
fMRI after surgery and IOP normalization (Li et al., 2017). The
decreased connectivity of the visual area reflects the decreased
compensation of other brain areas following the reduction of IOP
and improving vision.
On the contrary, some authors suggested a remarkable level
of stability within the adult primary and extrastriate visual
cortex, without any evidence of neurodegeneration affecting
cells receiving visual information of fellow eye in patients with
unilateral glaucoma (Borges et al., 2015).
Limits and Suggestion for Future Studies
Our study suffers from several limitations mainly due to
limitations associated with experimental design and available
tools of studies. First, different brain atlases were used to
annotate localization of cortical areas. Moreover, in regard to
the fMRI studies, differences in type, frequency, size, brightness,
and color of stimuli are present in different studies. Thus,
cortical activity is certainly influenced by the stimulus which
causes conclusions of studies to be partially conflicting with each
other. Another limitation consists in the heterogeneity of age of
patients, severity of damage and duration of disease between the
studies.
Some suggestion for future studies include a consistent
number of both glaucomatous and healthy subject, division of
glaucomatous patients in severity group through well-established
classification (i.e., Hodapp criteria), application of structural,
functional and metabolic methods. Correspondence of structural
and functional-metabolic abnormalities gives strength to
results.
Therapeutic Perspectives
The identification of neurodegeneration in the visual centers
of the brain has important implications for the treatment of
glaucoma. Emerging therapeutic interventions, such as RGC
transplantation and artificial retinal implants (Mathieson
et al., 2012; Venugopalan et al., 2016; Jutley et al., 2017;
Sena and Lindsley, 2017), need to consider the degree of
neurodegeneration in the posterior visual pathway as a
confounding factor in the efficacy of therapeutic interventions.
Glaucomatous neurodegeneration in the brain also has
implications for assessing the efficacy of neuroprotection,
suggesting that the focus of these therapies should be extended to
include the whole brain. Furthermore, abnormalities of the brain
should be included as endpoints in studies of therapeutic efficacy
in glaucoma trials.
CONCLUSION
Systematic review yields the advantage of aggregating
information and more robust estimates than individual
studies. This approach can be particularly useful when evaluating
new procedures with relatively small studies. Brain changes
in glaucomatous subjects have been proved with autoptic
and experimental studies in the past. Recently, the advent
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of non-invasive neuroimaging has led to a growth in studies
investigating the brain damage of glaucomatous patients.
The results of this meta-analysis show functional and
structural changes throughout the visual and nonvisual
pathway in glaucomatous patients. These changes correlate
with clinical findings and severity of the disease. Entity and
mechanism of cortical reorganization are still not completely
clear.
This review contributes to the better understanding of brain
abnormalities in glaucoma. The results may stimulate further
speculation about brain plasticity at a later age and therapeutic
strategies, such as the prevention of cortical degeneration in
patients with glaucoma.
AUTHOR CONTRIBUTIONS
RN conception and design of study. LD acquisition and analysis
of data. LD and TR drafting the manuscript. RN, LD, and
TR revising the manuscript critically for important intellectual
content. RN, LD, and TR approval of the version of the
manuscript to be published.
SUPPLEMENTARY MATERIAL




Agorastos, A., Skevas, C., Matthaei, M., Otte, C., Klemm, M.,
Richard, G., et al. (2013). Depression, anxiety, and disturbed
sleep in glaucoma. J. Neuropsychiatry Clin. Neurosci. 25, 205–213.
doi: 10.1176/appi.neuropsych.12020030
Alexander, A. L., Lee, J. E., Lazar, M., and Field, A. S. (2007).
Diffusion tensor imaging of the brain. Neurotherapeutics 4, 316–329.
doi: 10.1016/j.nurt.2007.05.011
Ashburner, J., and Friston, K. J. (2000). Voxel-based morphometry—the methods.
Neuroimage 11, 805–821. doi: 10.1006/nimg.2000.0582
Bayer, A. U., and Ferrari, F. (2002). Severe progression of glaucomatous
optic neuropathy in patients with Alzheimer’s disease. Eye 16, 209–212.
doi: 10.1038/sj.eye.6700034
Bayer, A. U., Ferrari, F., and Erb, C. (2002). High occurrence rate of
glaucoma among patients with Alzheimer’s disease. Eur. Neurol. 47, 165–168.
doi: 10.1159/000047976
Berry, K. P., and Nedivi, E. (2016). Experience-dependent structural
plasticity in the visual system. Annu. Rev. Vis. Sci. 2, 17–35.
doi: 10.1146/annurev-vision-111815-114638
Biswal, B. B., Mennes, M., Zuo, X. N., Gohel, S., Kelly, C., Smith, S. M., et al. (2010).
Toward discovery science of human brain function. Proc. Natl. Acad. Sci. U.S.A.
107, 4734–4739. doi: 10.1073/pnas.0911855107
Bogorodzki, P., Piatkowska-Janko, E., Szaflik, J., Szaflik, J. P., Gacek, M., and Grieb,
P. (2014). Mapping cortical thickness of the patients with unilateral end-stage
open angle glaucoma on planar cerebral cortex maps. PLoS ONE 9:e93682.
doi: 10.1371/journal.pone.0093682
Bolacchi, F., Garaci, F. G., Martucci, A., Meschini, A., Fornari, M., Marziali,
S., et al. (2012). Differences between proximal versus distal intraorbital optic
nerve diffusion tensor magnetic resonance imaging properties in glaucoma
patients. Invest. Ophthalmol. Vis. Sci. 53, 4191–4196. doi: 10.1167/iovs.
11-9345
Borges, V. M., Danesh-Meyer, H. V., Black, J. M., and Thompson, B. (2015).
Functional effects of unilateral open-angle glaucoma on the primary and
extrastriate visual cortex. J. Vis. 15:9. doi: 10.1167/15.15.9
Boucard, C. C., Hanekamp, S., Curcˇic´-Blake, B., Ida, M., Yoshida, M., and
Cornelissen, F. W. (2016). Neurodegeneration beyond the primary visual
pathways in a population with a high incidence of normal-pressure glaucoma.
Ophthalmic. Physiol. Opt. 36, 344–353. doi: 10.1111/opo.12297
Boucard, C. C., Hernowo, A. T., Maguire, R. P., Jansonius, N. M., Roerdink, J.
B., Hooymans, J. M., et al. (2009). Changes in cortical grey matter density
associated with long-standing retinal visual field defects. Brain 132, 1898–1906.
doi: 10.1093/brain/awp119
Boucard, C. C., Hoogduin, J. M., van der Grond, J., and Cornelissen, F. W. (2007).
Occipital proton magnetic resonance spectroscopy (1H-MRS) reveals normal
metabolite concentrations in retinal visual field defects. PLoS ONE 2:e222.
doi: 10.1371/journal.pone.0000222
Brown, H. D., Woodall, R. L., Kitching, R. E., Baseler, H. A., and Morland, A. B.
(2016). Using magnetic resonance imaging to assess visual deficits: a review.
Ophthalmic. Physiol. Opt. 36, 240–265. doi: 10.1111/opo.12293
Cai, F., Gao, L., Gong, H., Jiang, F., Pei, C., Zhang, X., et al. (2015). Network
centrality of resting-state fMRI in primary angle-closure glaucoma before and
after surgery. PLoS ONE 10:e0141389. doi: 10.1371/journal.pone.0141389
Calkins, D. J., andHorner, P. J. (2012). The cell andmolecular biology of glaucoma:
axonopathy and the brain. Invest. Ophthalmol. Vis. Sci. 53, 2482–2484.
doi: 10.1167/iovs.12-9483i
Chang, E. E., and Goldberg, J. L. (2012). Glaucoma 2.0: neuroprotection,
neuroregeneration, neuroenhancement. Ophthalmology 119, 979–986.
doi: 10.1016/j.ophtha.2011.11.003
Chen, W. W., Wang, N., Cai, S., Fang, Z., Yu, M., Wu, Q., et al. (2013).
Structural brain abnormalities in patients with primary open-angle glaucoma:
a study with 3T MR imaging. Invest. Ophthalmol. Vis. Sci. 54, 545–554.
doi: 10.1167/iovs.12-9893
Chen, W., Zhang, L., Xu, Y. G., Zhu, K., and Luo, M. (2017). Primary
angle-closure glaucomas disturb regional spontaneous brain activity in the
visual pathway: an fMRI study. Neuropsychiatr. Dis. Treat. 13, 1409–1417.
doi: 10.2147/NDT.S134258
Chen, Z., Lin, F., Wang, J., Li, Z., Dai, H., Mu, K., et al. (2013). Diffusion
tensor magnetic resonance imaging reveals visual pathway damage that
correlates with clinical severity in glaucoma. Clin. Exp. Ophthalmol. 1, 43–49.
doi: 10.1111/j.1442-9071.2012.02832.x
Clarkson, M. J., Cardoso, M. J., Ridgway, G. R., Modat, M., Leung, K.
K., Rohrer, J. D., et al. (2011). A comparison of voxel and surface
based cortical thickness estimation methods. Neuroimage 57, 856–865.
doi: 10.1016/j.neuroimage.2011.05.053
Crozier, R. A., Wang, Y., Liu, C. H., and Bear, M. F. (2007). Deprivation-
induced synaptic depression by distinct mechanisms in different layers
of mouse visual cortex. Proc. Natl. Acad. Sci. U.S.A. 104, 1383–1388.
doi: 10.1073/pnas.0609596104
Dai, H., Morelli, J. N., Ai, F., Yin, D., Hu, C., Xu, D., et al. (2013). Resting-
state functional MRI: functional connectivity analysis of the visual cortex in
primary open-angle glaucoma patients. Hum. Brain Mapp. 34, 2455–2463.
doi: 10.1002/hbm.22079
Davis, B. M., Crawley, L., Pahlitzsch, M., Javaid, F., and Cordeiro, M. F.
(2016). Glaucoma: the retina and beyond. Acta Neuropathol. 132, 807–826.
doi: 10.1007/s00401-016-1609-2
Duncan, R. O., Sample, P. A., Weinreb, R. N., Bowd, C., and Zangwill, L. M.
(2007a). Retinotopic organization of primary visual cortex in glaucoma: a
method for comparing cortical function with damage to the optic disk. Invest.
Ophthalmol. Vis. Sci. 48, 733–744. doi: 10.1167/iovs.06-0773
Duncan, R. O., Sample, P. A., Weinreb, R. N., Bowd, C., and Zangwill, L.
M. (2007b). Retinotopic organization of primary visual cortex in glaucoma:
comparing fMRI measurements of cortical function with visual field loss. Prog.
Retin. Eye Res. 26, 38–56. doi: 10.1016/j.preteyeres.2006.10.001
El-Rafei, A., Engelhorn, T., Wärntges, S., Dörfler, A., Hornegger, J., andMichelson,
G. (2011). A framework for voxel-based morphometric analysis of the optic
radiation using diffusion tensor imaging in glaucoma. Magn. Reson. Imaging
29, 1076–1087. doi: 10.1016/j.mri.2011.02.034
El-Rafei, A., Engelhorn, T., Wärntges, S., Dörfler, A., Hornegger, J., and
Michelson, G. (2013). Glaucoma classification based on visual pathway
Frontiers in Neuroscience | www.frontiersin.org 19 May 2018 | Volume 12 | Article 363
Nuzzi et al. Brain and Glaucoma: A Systematic Review
analysis using diffusion tensor imaging. Magn. Reson. Imaging 31, 1081–1091.
doi: 10.1016/j.mri.2013.01.001
Engelhorn, T., Michelson, G., Waerntges, S., Struffert, T., Haider, S., and Doerfler,
A. (2011). Diffusion tensor imaging detects rarefaction of optic radiation in
glaucoma patients. Acad. Radiol. 18, 764–769. doi: 10.1016/j.acra.2011.01.014
Fiedorowicz, M., Dyda, W., Rejdak, R., and Grieb, P. (2011). Magnetic
resonance in studies of glaucoma. Med. Sci. Monit. 17, RA227–R232.
doi: 10.12659/MSM.881973
Frezzotti, P., Giorgio, A., Motolese, I., De Leucio, A., Iester, M., Motolese,
E., et al. (2014). Structural and functional brain changes beyond visual
system in patients with advanced glaucoma. PLoS ONE 9:e105931.
doi: 10.1371/journal.pone.0105931
Frezzotti, P., Giorgio, A., Toto, F., De Leucio, A., and De Stefano, N. (2016). Early
changes of brain connectivity in primary open angle glaucoma. Hum. Brain
Mapp. 37, 4581–4596. doi: 10.1002/hbm.23330
Garaci, F. G., Bolacchi, F., Cerulli, A., Melis, M., Spanò A., Cedrone, C., et al.
(2009). Optic nerve and optic radiation neurodegeneration in patients with
glaucoma: in vivo analysis with 3-T diffusion-tensor MR imaging. Radiology
252, 496–501. doi: 10.1148/radiol.2522081240
Gerente, V. M., Schor, R. R., Chaim, K. T., Felix Mde, M., Ventura, D.
F., Teixeira, S. H., et al. (2015). Evaluation of glaucomatous damage
via functional magnetic resonance imaging, and correlations thereof with
anatomical and psychophysical ocular findings. PLoS ONE 10:e0126362.
doi: 10.1371/journal.pone.0126362
Giorgio, A., Zhang, J., Costantino, F., De Stefano, N., and Frezzotti, P. (2018).
Diffuse brain damage in normal tension glaucoma. Hum. Brain Mapp. 39,
532–541. doi: 10.1002/hbm.23862
Gupta, N., and Yücel, Y. H. (2003). Brain changes in glaucoma. Eur. J. Ophthalmol.
3, S32–S35. doi: 10.1177/112067210301303S06
Gupta, N., Ang, L.-C. C., Noel de Tilly, L., Bidaisee, L., Yucel, Y. H., Noël de
Tilly, L., et al. (2006). Human glaucoma and neural degeneration in intracranial
optic nerve, lateral geniculate nucleus, and visual cortex. Br. J. Ophthalmol. 90,
674–678. doi: 10.1136/bjo.2005.086769
Gupta, N., Yücel, Y. H., and Yucel, Y. H. (2007). Glaucoma as a
neurodegenerative disease. Curr. Opin. Ophthalmol. 18, 110–114
doi: 10.1097/ICU.0b013e3280895aea
Harwerth, R. S., Carter-Dawson, L., Shen, F., Smith, E. L. III., and Crawford, M. L.
(1999). Ganglion cell losses underlying visual field defects from experimental
glaucoma. Invest. Ophthalmol. Vis. Sci. 40, 2242–2250.
Harwerth, R. S., Carter-Dawson, L., Smith, E. L., and Crawford, M. L. J.
(2005). Scaling the structure–function relationship for clinical perimetry. Acta
Ophthalmol. Scand. 83, 448–455. doi: 10.1111/j.1395-3907.2005.00494.x
Hernowo, A. T., Boucard, C. C., Jansonius, N. M., Hooymans, J. M., and
Cornelissen, F. W. (2011). Automated morphometry of the visual pathway
in primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 52, 2758–2766.
doi: 10.1167/iovs.10-5682
Huang, X., Zhong, Y. L., Zeng, X. J., Zhou, F., Liu, X. H., Hu, P. H., et al. (2015).
Disturbed spontaneous brain activity pattern in patients with primary angle-
closure glaucoma using amplitude of low-frequency fluctuation: a fMRI study.
Neuropsychiatr. Dis. Treat. 11, 1877–1883. doi: 10.2147/NDT.S87596
Jiang, M. M., Zhou, Q., Liu, X. Y., Shi, C. Z., Chen, J., and Huang, X. H.
(2017). Structural and functional brain changes in early- andmid-stage primary
open-angle glaucoma using voxel-basedmorphometry and functional magnetic
resonance imaging.Medicine 96:e6139. doi: 10.1097/MD.0000000000006139
Jutley, G., Luk, S. M., Dehabadi, M. H., and Cordeiro, M. F. (2017). Management
of glaucoma as a neurodegenerative disease. Neurodegener. Dis. Manag. 7,
157–172. doi: 10.2217/nmt-2017-0004
Kapetanakis, V. V., Chan, M. P., Foster, P. J., Cook, D. G., Owen, C. G., and
Rudnicka, A. R. (2016). Global variations and time trends in the prevalence of
primary open angle glaucoma (POAG): a systematic review and meta-analysis.
Br. J. Ophthalmol. 100, 86–93. doi: 10.1136/bjophthalmol-2015-307223
Kaushik, M., Graham, S. L., Wang, C., and Klistorner, A. (2014). A
topographical relationship between visual field defects and optic radiation
changes in glaucoma. Invest. Ophthalmol. Vis. Sci. 55, 5770–5775.
doi: 10.1167/iovs.14-14733
Kerrigan-Baumrind, L. A., Quigley, H. A., Pease, M. E., Kerrigan, D. F., and
Mitchell, R. S. (2000). Number of ganglion cells in glaucoma eyesccompared
with threshold visual field tests in the same persons. Invest. Ophthalmol. Vis.
Sci. 41, 741–748.
Kollias, S. S. (2004). Investigations of the human visual system using
functional magnetic resonance imaging (FMRI). Eur. J. Radiol. 49, 64–75.
doi: 10.1016/j.ejrad.2003.09.005
Kong, X., Yan, M., Sun, X., Xiao, Z. (2015). Anxiety and depression are more
prevalent in primary angle closure glaucoma than in primary open-angle
glaucoma. J. Glaucoma 24, e57–e63. doi: 10.1097/IJG.0000000000000025
Lestak, J., Tintera, J., Svata, Z., Ettler, L., and Rozsival, P. (2014). Glaucoma and
CNS. comparison of fMRI results in high tension and normal tension glaucoma.
Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 158, 144–153.
doi: 10.5507/bp.2013.038
Li, C., Cai, P., Shi, L., Lin, Y., Zhang, J., Liu, S., et al. (2012). Voxel-based
morphometry of the visual-related cortex in primary open angle glaucoma.
Curr. Eye Res. 37, 794–802. doi: 10.3109/02713683.2012.683506
Li, S., Li, P., Gong, H., Jiang, F., Liu, D., Cai, F., et al. (2017). Intrinsic functional
connectivity alterations of the primary visual cortex in primary angle-closure
glaucoma patients before and after surgery: a resting-state fMRI study. PLoS
ONE 12:e0170598. doi: 10.1371/journal.pone.0170598
Li, T., Liu, Z., Li, J., Liu, Z., Tang, Z., Xie, X., et al. (2014). Altered
amplitude of low-frequency fluctuation 656 in primary open-angle glaucoma:
a resting-state FMRI study. Invest. Ophthalmol. Vis. Sci. 56, 322–329.
doi: 10.1167/iovs.14-14974
Lu, P., Shi, L., Du, H., Xie, B., Li, C., Li, S., et al. (2013). Reduced white matter
integrity in primary open-angle glaucoma: a DTI study using tract-based spatial
statistics. J. Neuroradiol. 40, 89–93. doi: 10.1016/j.neurad.2012.04.001
Mastropasqua, R., Agnifili, L., Mattei, P. A., Caulo, M., Fasanella, V., Navarra,
R., et al. (2015). Advanced morphological and functional magnetic
resonance techniques in glaucoma. Biomed. Res. Int. 2015:160454.
doi: 10.1155/2015/160454
Mathieson, K., Loudin, J., Goetz, G., Huie, P., Wang, L., Kamins, T. I., et al.
(2012). Photovoltaic retinal prosthesis with high pixel density. Nat. Photonics
6, 391–397. doi: 10.1038/nphoton.2012.104
McKinnon, S. J. (2012). The cell and molecular biology of glaucoma: common
neurodegenerative pathways and relevance to glaucoma. Invest. Ophthalmol.
Vis. Sci. 53, 2485–2487. doi: 10.1167/iovs.12-9483j
Michelson, G., Engelhorn, T.,Wärntges, S., El Rafei, A., Hornegger, J., andDoerfler,
A. (2013). DTI parameters of axonal integrity and demyelination of the optic
radiation correlate with glaucoma indices. Graefes Arch. Clin. Exp. Ophthalmol.
251, 243–253. doi: 10.1007/s00417-011-1887-2
Miki, A., Haselgrove, J. C., and Liu, G. T. (2002). Functional magnetic resonance
imaging and its clinical utility in patients with visual disturbances. Surv.
Ophthalmol. 47, 562–579. doi: 10.1016/S0039-6257(02)00356-9
Miki, A., Liu, G. T., Modestino, E. J., Liu, C. S., Bonhomme, G. R., Dobre, C. M.,
et al. (2001). Functional magnetic resonance imaging of the visual system. Curr.
Opin. Ophthalmol. 12, 423–431. doi: 10.1097/00055735-200112000-00007
Murai, H., Suzuki, Y., Kiyosawa, M., Tokumaru, A. M., Ishiwata, K., and Ishii, K.
(2015). Cerebral glucose metabolism in the striate cortex positively correlates
with fractional anisotropy values of the optic radiation in patients with
glaucoma. Clin. Exp. Ophthalmol. 43, 711–719. doi: 10.1111/ceo.12543
Murphy, M. C., Conner, I. P., Teng, C. Y., Lawrence, J. D., Safiullah Z1, Wang, B.,
et al. (2016). Retinal structures and visual cortex activity are impaired prior to
clinical vision loss in glaucoma. Sci. Rep. 6:31464. doi: 10.1038/srep31464
Nucci, C., Mancino, R., Martucci, A., Bolacchi, F., Manenti, G., et al.
(2012). 3-T Diffusion tensor imaging of the optic nerve in subjects
with glaucoma: correlation with GDx-VCC, HRT-III and Stratus
optical coherence tomography findings. Br. J. Ophthalmol. 96, 976–980.
doi: 10.1136/bjophthalmol-2011-301280
Omodaka, K., Murata, T., Sato, S., Takahashi, M., Tatewaki, Y., Nagasaka, T., et al.
(2014). Correlation of magnetic resonance imaging optic nerve parameters
to optical coherence tomography and the visual field in glaucoma. Clin. Exp.
Ophthalmol. 42, 360–368. doi: 10.1111/ceo.12237
Prins, D., Hanekamp, S., and Cornelissen, F. W. (2016). Structural brain MRI
studies in eye diseases: are they clinically relevant? Rev. Curr. Findings Acta
Ophthalmol. 94, 113–121. doi: 10.1111/aos.12825
Qing, G., Zhang, S., Wang, B., and Wang, N. (2010). Functional MRI signal
changes in primary visual cortex corresponding to the central normal visual
Frontiers in Neuroscience | www.frontiersin.org 20 May 2018 | Volume 12 | Article 363
Nuzzi et al. Brain and Glaucoma: A Systematic Review
field of patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis.
Sci. 51, 4627–4634. doi: 10.1167/iovs.09-4834
Quigley, H. A., Dunkelberger, G. R., and Green, W. R. (1989). Retinal ganglion cell
atrophy correlated with automated perimetry in human eyes with glaucoma.
Am. J. Ophthalmol. 107, 453–464. doi: 10.1016/0002-9394(89)90488-1
Rolle, T., Dallorto, L., and Bonetti, B. (2016). Retinal and macular ganglion
cell count estimated with optical coherence tomography RTVUE-100 as a
candidate biomarker for glaucoma. Invest. Ophthalmol. Vis. Sci. 57, 5772–5779.
doi: 10.1167/iovs.15-18882
Rosa, A. M., Silva, M. F., Ferreira, S., Murta, J., and Castelo-Branco, M. (2013).
Plasticity in the human visual cortex: an ophthalmology-based perspective.
Biomed. Res. Int. 2013, 1–13. doi: 10.1155/2013/568354
Schoemann, J., Engelhorn, T., Waerntges, S., Doerfler, A., El-Rafei, A., and
Michelson, G. (2014). Cerebral microinfarcts in primary open-angle glaucoma
correlated with DTI-derived integrity of optic radiation. Invest. Ophthalmol.
Vis. Sci. 55, 7241–7247. doi: 10.1167/iovs.14-14919
Sena, D. F., and Lindsley, K. (2017). Neuroprotection for treatment
of glaucoma in adults. Cochrane Database Syst. Rev. 25:CD006539.
doi: 10.1002/14651858.CD006539.pub4
Sidek, S., Ramli, N., Rahmat, K., Ramli, N. M., Abdulrahman, F., and Tan,
L. K. (2014). Glaucoma severity affects diffusion tensor imaging (DTI)
parameters of the optic nerve and optic radiation. Eur. J. Radiol. 83, 1437–1441.
doi: 10.1016/j.ejrad.2014.05.014
Smitha, K. A., Akhil Raja, K., Arun, K. M., Rajesh, P. G., Thomas, B.,
Kapilamoorthy, T. R., et al. (2017). Resting state fMRI: a review on methods
in resting state connectivity analysis and resting state networks. Neuroradiol. J.
30, 305–317. doi: 10.1177/1971400917697342
Song, X., Wang, G., Zhang, T., Feng, L., An, P., and Zhu, Y. (2012).
Functional magnetic resonance imaging evaluation of visual cortex activation
in patients with anterior visual pathway lesions. Neural Regen. Res. 7, 692–696.
doi: 10.3969/j.issn.1673-5374.2012.09.009
Song, Y., Mu, K., Wang, J., Lin, F., Chen, Z., Yan, X., et al. (2014). Altered
spontaneous brain activity in primary open angle glaucoma: a resting-
state functional magnetic resonance imaging study. PLoS ONE 9:e89493.
doi: 10.1371/journal.pone.0089493
Tamura, H., Kawakami, H., Kanamoto, T., Kato, T., Yokoyama, T., Sasaki, K.,
et al. (2006). High frequency of open-angle glaucoma in Japanese patients with
Alzheimer’s disease. J. Neurol. Sci. 246, 79–83. doi: 10.1016/j.jns.2006.02.009
Tellouck, L., Durieux, M., Coupé P., Cougnard-Grégoire, A., Tellouck, J.,
Tourdias, T., et al. (2016). Optic radiations microstructural changes in
glaucoma and association with severity: a study using 3tesla-magnetic
resonance diffusion tensor imaging. Invest. Ophthalmol. Vis. Sci. 57, 6539–6547.
doi: 10.1167/iovs.16-19838
Tham, Y.-C. C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., Ed, F.,
et al. (2014). Global prevalence of glaucoma and projections of glaucoma
burden through 2040. Syst. Rev. Meta Analysis Ophthalmol. 121, 2081–2090.
doi: 10.1016/j.ophtha.2014.05.013
Venugopalan, P., Wang, Y., Nguyen, T., Huang, A., Muller, K. J., and Goldberg,
J. L. (2016). Transplanted neurons integrate into adult retinas and respond to
light. Nat. Commun. 7:10472. doi: 10.1038/ncomms10472
Wang, J., Li, T., Sabel, B. A., Chen, Z., Wen, H., Li, J., et al. (2016). Structural brain
alterations in primary open angle glaucoma: a 3T MRI study. Sci. Rep. 6:18969.
doi: 10.1038/srep18969
Wang, J., Li, T., Wang, N., Xian, J., and He, H. (2016a). Graph theoretical analysis
reveals the reorganization of the brain network pattern in primary open angle
glaucoma patients. Eur. Radiol. 26, 3957–3967. doi: 10.1007/s00330-016-4221-x
Wang, J., Li, T., Zhou, P.,Wang, N., Xian, J., andHe, H. (2016b). Altered functional
connectivity within and between the default model network and the visual
network in primary open-angle glaucoma: a resting-state fMRI study. Brain
Imaging Behav. 11, 1154–1163. doi: 10.1007/s11682-016-9597-3.
Wang, M. Y., Wu, K., Xu, J. M., Dai, J., Qin, W., Liu, J., et al. (2013). Quantitative
3-T diffusion tensor imaging in detecting optic nerve degeneration in patients
with glaucoma: association with retinal nerve fiber layer thickness and clinical
severity. Neuroradiology 55, 493–498. doi: 10.1007/s00234-013-1133-1
Weinreb, R. N., Aung, T., and Medeiros, F. A. (2014). The pathophysiology
and treatment of glaucoma: a review. JAMA 311, 1901–1911.
doi: 10.1001/jama.2014.3192
Williams, A. L., Lackey, J., Wizov, S. S., Chia, T. M., Gatla, S., Moster, M. L.,
et al. (2013). Evidence for widespread structural brain changes in glaucoma: a
preliminary voxel-basedMRI study. Invest. Ophthalmol. Vis. Sci. 54, 5880–5887.
doi: 10.1167/iovs.13-11776
Wostyn, P., Audenaert, K., and De Deyn, P. P. (2009). Alzheimer’s disease and
glaucoma: is there a causal relationship? Br. J. Ophthalmol. 93, 1557–1559.
doi: 10.1136/bjo.2008.148064
Wostyn, P., Audenaert, K., and De Deyn, P. P. (2010). Alzheimer’s disease: cerebral
glaucoma?Med. Hypotheses 74, 973–977 doi: 10.1016/j.mehy.2009.12.019
Yu, L., Xie, B., Yin, X., Liang, M., Evans, A. C., Wang, J., et al. (2013).
Reduced cortical thickness in primary open-angle glaucoma and its
relationship to the retinal nerve fiber layer thickness. PLoS ONE 8:e73208.
doi: 10.1371/journal.pone.0073208
Yu, L., Xie, L., Dai, C., Xie, B., Liang, M., Zhao, L., et al. (2015). Progressive
thinning of visual cortex in primary open-angle glaucoma of varying severity.
PLoS ONE 10:e0121960. doi: 10.1371/journal.pone.0121960
Yu, L., Yin, X., Dai, C., Liang, M.,Wei, L., Li, C., et al. (2014). Morphologic changes
in the anterior and posterior subregions of V1 and V2 and the V5/MT+
in patients with primary open-angle glaucoma. Brain Res. 1588, 135–143.
doi: 10.1016/j.brainres.2014.09.005
Yücel, Y. H., Zhang, Q., Gupta, N., Kaufman, P. L., and Weinreb, R. N.
(2000). Loss of neurons in magnocellular and parvocellular layers of the
lateral geniculate nucleus in glaucoma. Arch. Ophthalmol. 118, 378–384.
doi: 10.1001/archopht.118.3.378
Yücel, Y. H., Zhang, Q., Weinreb, R. N., Kaufman, P. L., and Gupta, N. (2001).
Atrophy of relay neurons in magno- and parvocellular layers in the lateral
geniculate nucleus in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 42,
3216–3222.
Zhang, P., Wen, W., Sun, X., and He, S. (2016). Selective reduction of fMRI
responses to transient achromatic stimuli in the magnocellular layers of the
LGN and the superficial layer of the SC of early glaucoma patients.Hum. Brain
Mapp. 37, 558–569. doi: 10.1002/hbm.23049
Zhang, S.,Wang, B., Xie, Y., Zhu, S., Thomas, R., Qing, G., et al. (2015). Retinotopic
changes in the graymatter volume and cerebral blood flow in the primary visual
cortex of patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis.
Sci. 56, 6171–6178. doi: 10.1167/iovs.15-17286
Zhang, Y. Q., Li, J., Xu, L., Zhang, L., Wang, Z. C., Yang, H., et al.
(2012). Anterior visual pathway assessment by magnetic resonance
imaging in normal-pressure glaucoma. Acta Ophthalmol. 90, e295–e302.
doi: 10.1111/j.1755-3768.2011.02346.x
Zhang, Y., Chen, X., Wen, G., Wu, G., and Zhang, X. (2013). Proton
magnetic resonance spectroscopy [(1)H-MRS] reveals geniculocalcarine
and striate area degeneration in primary glaucoma. PLoS ONE 8:e73197.
doi: 10.1371/journal.pone.0073197
Zhou,W., Muir, E. R., Chalfin, S., Nagi, K. S., and Duong, T. Q. (2017a). MRI study
of the posterior visual pathways in primary open angle glaucoma. J. Glaucoma
26, 173–181. doi: 10.1097/IJG.0000000000000558
Zhou, W., Muir, E. R., Nagi, K. S., Chalfin, S., Rodriguez, P., and Duong,
T. Q. (2017b). Retinotopic fMRI reveals visual dysfunction and functional
reorganization in the visual cortex of mild to moderate glaucoma patients. J.
Glaucoma 26, 430–437. doi: 10.1097/IJG.0000000000000641
Zikou, A. K., Kitsos, G., Tzarouchi, L. C., Astrakas, L., Alexiou, G. A., and
Argyropoulou, M. I. (2012). Voxel-based morphometry and diffusion tensor
imaging of the optic pathway in primary open-angle glaucoma: a preliminary
study. Am. J. Neuroradiol. 33, 128–134. doi: 10.3174/ajnr.A2714
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Nuzzi, Dallorto and Rolle. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Neuroscience | www.frontiersin.org 21 May 2018 | Volume 12 | Article 363
